Thanks to combination antiretroviral therapy, many people with HIV can be expected to live decades after being infected. Yet doctors have observed that these patients often show signs of premature aging. Now a study published ...
Apr 21, 2016
0
11
Under the trade name Edurant, rilpivirine as single agent has been approved already since 2011 for adults who are infected with human immunodeficiency virus type 1 (HIV-1). Since November 2015, HIV-1-infected children and ...
Apr 1, 2016
0
1
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, ...
Mar 21, 2016
0
15
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study—a 10-nation, randomized clinical trial of adult outpatients—investigators concluded that there ...
Mar 17, 2016
0
5
Highly active antiretroviral therapy (HAART) and direct acting antiviral agents (DAAs) are key elementsin the effective pharmacotherapy of human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) respectively.
Mar 14, 2016
0
0
Some people with HIV infection experience a limited recovery of their T cell counts after they start antiretroviral therapy, even though the virus is well controlled. This leaves them at higher risk for other infections, ...
Mar 8, 2016
0
7
An immune-enhancing treatment can push SIV (simian immunodeficiency virus) out of its hideouts in infected monkeys that have the virus controlled with drugs, scientists at Yerkes National Primate Research Center, Emory University ...
Feb 25, 2016
0
7
Addition of the integrase strand transfer inhibitor raltegravir (RAL) to standard antiretroviral therapy (ART) in ART-naive patients with early HIV infection was not associated with a difference in the quantity of HIV DNA, ...
Feb 22, 2016
0
0
New research from the University of Alberta's School of Dentistry shows that a commonly used cholesterol-lowering drug could help people with HIV live longer and enjoy an improved quality of life.
Feb 22, 2016
0
338
(Medical Xpress)—It's a good news/bad news scenario: Researchers have made a new discovery about HIV that will redirect curative strategies toward latent reservoirs of HIV—that's the good news. The bad news is that they ...
